1. Garner PR: Disorder of the Adrenal Cortex in pregnancy. Curr Obstet Med. 1993; 2:143-193.

2. Whitely HJ, Stoner HB: The effect of pregnancy on the Adrenal Cortex. J. Endocrinol. 1957; 14:325.

3. Taylor AL, Fishman LM: Corticotropin-releasing Hormone. N Engl J Med. 1988; 319; 213.

4. Sasaki A, Shinkawa O, Yoshinaaga K: Placental corticotropin-releasing hormone may be a stimulator of maternal pituitary adrenocorticotropic hormone secretion in humans. J Clin Invest. 1989; 84; 1997-2001.

5. Goland RS, Wardlaw SL, Stark RI, et al: High levels of CRH Immunoactivity in Maternal and Fetal plasma during pregnancy. J Clin Endocrinol Metab. 1986; 63:1199.

6. McLean M, Smith R: Corticotropin-releasing hormone and human parturition. Reproduction. 2001; 121; 493.

7. Rees LH, Burke CW, Chard R, et al: Possible placental origin of ACTH in normal human pregnancy. Nature; 1975; 254:620.

8. Scott EM, McGarrigle HHG, Lachelin GCL: The increase in Plasma and Saliva Cortisol Levels in pregnancy is not due to the increased Corticosteroid-Binding Globulin levels. J Clin Endocrinol Metab. 1990; 71:639.

9. Anderson KJ, Walters WAW: Cushing's Syndrome in pregnancy. Aus NZ J Obstet Gynecol. 1974; 43:861.

10. Demey-Ponsart E, Foidart JM, Sulon J, et al: Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. J Steroid Biochem. 1982; 16:165.

11. Kaplan NM: Endocrine Hypertension. In Wilson JD, Foster DW, eds. Williams Text Book of Endocrinology 8th Edition, Philadelphia: WB Saunders 1992: 707-731.

12. Wilson M, Morganti AA, Zervoudakis I, Letcher RL, et al: Blood pressure, the Renin-Aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980; 68:97-104.

13. Gant NF, Daley GL, Chand S, et al: A study of Angiotensin II pressor response throughout normal pregnancy. J Clin. Invest 1973; 52:2682.

14. Buescher MA, McClamrock HD, Adashi EY: Cushing's Syndrome in pregnancy. Obstet Gynecol. 1992:79;130.

15. Collaborative Group on Antenatal Steroid Therapy. Effects of antenatal Dexamethasone administration in the infant: long term follow-up. J Pediatr 1984: 104;259.

16. Pinette MG, Pan YQ, Oppenheim D, et al: Bilateral inferior petrosal sinus corticotropin sampling with CRH stimulation in a pregnant patient with Cushing's Syndrome. Am J Obstet Gynecol. 1994: 171;563.

17. Pricolo VE, Monchik JM, Prinz RA, et al: Management of Cushing's Syndrome secondary to Adrenal Adenoma in pregnancy. Surgery. 1990: 108;1072.

18. Hana V, Dokoupilova M, Marek J, Plavka R: Recurrent ACTH-independent Cushing's Syndrome in multiple pregnancies and its treatment with Metyrapone. Clin. Endocrinol (Oxf) 2001: 54;277.

19. Solomon GC, Thiet M, Moore F, Seely EW: Primary Hyperaldosteronism in Pregnancy. Obstet Gynecol. 1996: 41;255.

20. Hammond TG, Buchanan JG, Scoggins BA, et al: Primary Hyperaldosteronism in Pregnancy. Aus NZ J Med. 1982: 12;537.

21. Laurel MT, Kabadi UM: Primary Hyperaldosteronism. Endocrine Practice 1997: 3;47.

22. Baron F, Sprauve ME, Hiddleston JF, Fisher AJ: Diagnosis and Surgical treatment of Primary Hyperaldosteronism in Pregnancy. Obstet Gynecol. 1995: 86;644.

23. Smith HC, Posen S, Clitton-Bligh, et al: A testosterone-secreting adrenal cortical adenoma. Aus NZ J Med. 1978: 8;171.

24. Simmer HH, Frankland MV, Greipel M: Plasma testosterone in maternal peripheral blood and in cord venous blood after administration of testosterone enanthate to the mother. Steroids. 1972: 19;229.

25. Volpe R: Autoimmunity in the Endocrine System. Monogr Endocrinol. 1981: 20;149.

26. Kendall-Taylor P, Lambert A, Mitchell R, et al: Antibody that blocks stimulation of cortisol secretion by ACTH in Addison's Disease. BMJ 1988: 296;1489.

27. Khunda S: Pregnancy and Addison's Disease. Obstet Gynecol. 1972: 39;431.

28. Clayton RN: Diagnosis of adrenal insufficiency (editorial) BMJ 1989: 298;271.

29. Arad I, Landau H: Adrenocortical reserve of neonates born of long term steroid treated mothers. Eur J Pediatr. 1984: 142;279.

30. Osler M: Addison's Disease and Pregnancy. Acta Endocrinol (Copenh) 1962: 41;67.

31. MacGillivray I: Acute suprarenal insufficiency in pregnancy. BMJ 1951:2;212.

32. Kalaitzoglou G, New MI: Congenital adrenal hyperplasia. Molecular insights learned from patients. Receptor 1993: 3;211.

33. Gonzalez FJ: The molecular biology of cytochrome P450's. Pharmacol Rev 1989:40;243.

34. Garner PR: Congenital Adrenal Hyperplasia in pregnancy. Sem Perinatol 1998:22;446.

35. Jaaskelainen J, et al: Child rate, pregnancy outcome and ovarian function in females with classical 21-Hydroxylase deficiency. Acta Obstet Gynecol. Scand 2000: 79;687.

36. Mulaikal RM, Migeon CJ, Rock JA: Fertility rates in female patients with congenital adrenal hyperplasia due to 21-Hydroxylase deficiency. N Eng J Med. 1987: 316;178.

37. Cohen MA, Saver MV, Lindheim SR: 21-Hydroxylase deficiency and Turner's Syndrome: a reason for diminished endometrial receptivity. Fertil Steril. 1999: 72;937.

38. Hague WM, Adams J, Rodda C, et al: The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol. (Oxf) 1990: 36;53.

39. Mercado AB, Wilson RC, Cheng KC, Wei J, New MI: Prenatal treatment and diagnosis of congenital adrenal hyperplasia due to steroid 21-Hydroxylase deficiency. J Clin Endocrinol Metab. 1995: 80;2014.

40. Fainstat T: Cortisone-induced congenital cleft palate in rabbits. Endocrinol 1954:55;502.

41. Pang S: Congenital Adrenal Hyperplasia. Endocrinol Metab Clin Nort Am.1997:26;853.

42. Avni EF, Rypens F, Smet MH, Galletty E: Sonographic demonstration of congenital adrenal hyperplasia in the neonate: the cerebriform pattern. Pediatr Radiol 1993: 23;88.

43. Geley S, Kapelari K, Johrer K, et al: CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta-Hydroxylase deficiency. J Clin Endocrinol Metab. 1996: 81;2896.

44. Cathelineau G, Brerault JL, Fret J, et al: Adrenocortical 11 beta-Hydroxylase deficiency in adult women with post-menarchal onset of symptoms. J Clin Endocrinol Metab. 1980: 51;287.

45. Nasir J, Royston C, Walton C, et al: 11 beta-Hydroxylase deficiency: Management of a difficult case by laparoscopic bilateral adrenalectomy. Clin Endocrinol 1996: 45;225.

46. Schumert Z, Rosenman A, Landau H, et al: 11-Deoxycortisol in amniotic fluid. Prenatal diagnosis of congenital adrenal hyperplasia due to 11 beta-Hydroxylase deficiency. Clin Endocrinol 1980: 12;257.

47. Bouchard M, Forest MG, David M, et al: Familial congenital adrenal hyperplasia caused by 11 beta-Hydroxylase deficiency: Failure of prevention of sexual ambiguity and prenatal diagnosis. Pediatric 1989:44;637.

48. Ricketts SJ, Moisan AM, Tardy V, et al: A new insight into the molecular basis of 3 beta-hydroxysteroid dehydrogenase deficiency. Endocr Res 2000: 26;761.

49. Lobo RA, Goebelsman V: Evidence for reduced 3 beta-HSD activity in some hirsute women thought to have polycystic ovarian disease. J Clin Endocrinol Metab. 1981: 55;394.

50. Rojansky N, Shushan A, Rosler A, et al: Long term infertility in late-onset 3 beta-HSD Deficiency: successful pregnancy following Dexamethasone and in vitro fertilization. J In Vitro Fert Embryo Transf. 1991: 8;298.